Hollysys to Provide Supervisory Control and Data Acquisition System for Shenzhen Subway Line 11

Hollysys Automation Technologies, Ltd., a leading provider of automation and control technologies and applications in China, announced today that it has won the contract to supply its proprietary supervisory control and data acquisition system (SCADA) to Shenzhen Subway Line 11, valued at approximately USD $21.26 million or RMB 130 million.

Shenzhen Subway Line 11 is an airport express line, connecting Futian, Nanshan, and Baoan Districts, with 18 stations and 51.9 km in total length. The trial operation is scheduled in June 2016.

Hollysys is contracted to provide SCADA system based on its proprietary MACS-SCADA software platform, including software platform, system design, application development, hardware integration, installation, testing, maintenance and services. Hollysys will also provide its proprietary LM PLC to its PSCADA (Power SCADA) and apply total solution based on our previous successful experience in Beijing, Guangzhou, Shenzhen subway lines to ensure local customers' needs and design requirements as well as technology application are satisfied overall.

Hollysys' management commented, "We are very pleased to win the bidding from Shenzhen Metro Group to supply our proprietary SCADA systems for Subway Line 11. As China's subway build-up accelerates nationwide, Hollysys will continue to leverage on its solid and successful track record to gain its fair share in this booming market, further validates our well-established brand name recognition in China, and create value for our shareholders."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.